| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |